chartoreg 80 new

Chartoreg 80 mg is a pharmaceutical product containing Gliclazide, a second-generation sulfonylurea used primarily in the management of type 2 diabetes mellitus. It works by stimulating the release of insulin from the pancreatic beta cells, thereby helping to lower blood glucose levels. It is typically prescribed for patients whose blood sugar levels are not adequately controlled by diet and exercise alone. This medication should be used as part of a comprehensive diabetes management plan, including lifestyle modifications and regular monitoring of blood glucose levels as directed by a healthcare professional.